NO20010629L - FremgangsmÕte for fremstilling av en ikke-krystallinsk anhydratform av paroksetinhydroklorid - Google Patents

FremgangsmÕte for fremstilling av en ikke-krystallinsk anhydratform av paroksetinhydroklorid

Info

Publication number
NO20010629L
NO20010629L NO20010629A NO20010629A NO20010629L NO 20010629 L NO20010629 L NO 20010629L NO 20010629 A NO20010629 A NO 20010629A NO 20010629 A NO20010629 A NO 20010629A NO 20010629 L NO20010629 L NO 20010629L
Authority
NO
Norway
Prior art keywords
paroxetine hydrochloride
preparing
anhydrate form
crystalline anhydrate
propan
Prior art date
Application number
NO20010629A
Other languages
English (en)
Norwegian (no)
Other versions
NO20010629D0 (no
Inventor
Victor Witold Jacewicz
Neal Ward
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9817196.0A external-priority patent/GB9817196D0/en
Priority claimed from GBGB9828777.4A external-priority patent/GB9828777D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20010629D0 publication Critical patent/NO20010629D0/no
Publication of NO20010629L publication Critical patent/NO20010629L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20010629A 1998-08-07 2001-02-06 FremgangsmÕte for fremstilling av en ikke-krystallinsk anhydratform av paroksetinhydroklorid NO20010629L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9817196.0A GB9817196D0 (en) 1998-08-07 1998-08-07 Novel process
GBGB9828777.4A GB9828777D0 (en) 1998-12-29 1998-12-29 Novel compounds
PCT/GB1999/002592 WO2000008017A1 (en) 1998-08-07 1999-08-06 Process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride

Publications (2)

Publication Number Publication Date
NO20010629D0 NO20010629D0 (no) 2001-02-06
NO20010629L true NO20010629L (no) 2001-03-20

Family

ID=26314179

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010629A NO20010629L (no) 1998-08-07 2001-02-06 FremgangsmÕte for fremstilling av en ikke-krystallinsk anhydratform av paroksetinhydroklorid

Country Status (23)

Country Link
EP (2) EP1100796B1 (de)
JP (1) JP2002522434A (de)
KR (1) KR20010072323A (de)
CN (1) CN1321155A (de)
AP (2) AP0102072A0 (de)
AT (1) ATE239016T1 (de)
AU (1) AU5428999A (de)
BG (1) BG105310A (de)
BR (1) BR9912858A (de)
CA (1) CA2339857A1 (de)
DE (1) DE69907467T2 (de)
DK (1) DK1100796T3 (de)
EA (1) EA200100221A1 (de)
ES (1) ES2198940T3 (de)
HU (1) HUP0105466A3 (de)
ID (1) ID27914A (de)
IL (1) IL141286A0 (de)
NO (1) NO20010629L (de)
PL (1) PL345885A1 (de)
PT (1) PT1100796E (de)
SK (1) SK1972001A3 (de)
TR (1) TR200100444T2 (de)
WO (1) WO2000008017A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1394160A1 (de) 1996-06-13 2004-03-03 SUMIKA FINE CHEMICALS Co., Ltd. Verfahren zur Herstellung von kristallinem Paroxetin-Hydrochlorid
JP3796351B2 (ja) * 1998-04-13 2006-07-12 住友化学株式会社 パロキセチン塩酸塩無水和物の乾燥方法
GB9923446D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
EP1345955B1 (de) * 2000-11-17 2008-08-20 Eli Lilly And Company Lactam dipeptid und dessen verwendung zur inhibierung der beta-amyloid peptid frisetzung
WO2004035052A1 (ja) 2002-10-16 2004-04-29 Takeda Pharmaceutical Company Limited 安定な固形製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
EP0223403B1 (de) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel
AR001982A1 (es) * 1995-02-06 1998-01-07 Smithkline Beecham Plc Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion
EP0952831A1 (de) * 1997-01-15 1999-11-03 Smithkline Beecham Plc Paroxetinhaltige arzneizubereitungen
JP3796351B2 (ja) * 1998-04-13 2006-07-12 住友化学株式会社 パロキセチン塩酸塩無水和物の乾燥方法

Also Published As

Publication number Publication date
HK1038230A1 (en) 2002-03-08
ATE239016T1 (de) 2003-05-15
EA200100221A1 (ru) 2001-08-27
BR9912858A (pt) 2001-11-20
BG105310A (en) 2001-12-29
ES2198940T3 (es) 2004-02-01
WO2000008017A1 (en) 2000-02-17
DE69907467T2 (de) 2004-03-11
EP1321465A2 (de) 2003-06-25
AP2001002072A0 (en) 2001-03-31
EP1100796A1 (de) 2001-05-23
HUP0105466A3 (en) 2002-11-28
TR200100444T2 (tr) 2001-07-23
AU5428999A (en) 2000-02-28
HUP0105466A2 (hu) 2002-05-29
EP1321465A3 (de) 2003-09-03
EP1100796B1 (de) 2003-05-02
CN1321155A (zh) 2001-11-07
DE69907467D1 (de) 2003-06-05
NO20010629D0 (no) 2001-02-06
AP0102072A0 (en) 2001-02-06
PT1100796E (pt) 2003-09-30
KR20010072323A (ko) 2001-07-31
IL141286A0 (en) 2002-03-10
ID27914A (id) 2001-05-03
JP2002522434A (ja) 2002-07-23
SK1972001A3 (en) 2001-08-06
PL345885A1 (en) 2002-01-14
CA2339857A1 (en) 2000-02-17
DK1100796T3 (da) 2003-08-25

Similar Documents

Publication Publication Date Title
NO20022846L (no) Fremgangsmåte for å kondensere naturgass ved ekspansjonskjöling
DE59701369D1 (de) Thermisch härtbare, wässrige zusammensetzungen
PT1129633E (pt) Barreira isolante termica antifogo, processo de fabrico de uma tal barreira, vestuario que compreende pelo menos uma tal barreira na qualidade de isolamento interno
DK0766668T3 (da) Fremgangsmåde til fremstilling af vandfrie og hydratformer af som antihistaminer anvendelige piperidinderivater, polymorfer og pseudo-morfer deraf
MY119800A (en) Pyridine derivatives
PT923554E (pt) N-benzilpiperidina e derivados tetrahidropiridina
DK0772604T3 (da) Trialzolforbindelser og deres anvendelse som dopamin-D3-ligander
NO20010629L (no) FremgangsmÕte for fremstilling av en ikke-krystallinsk anhydratform av paroksetinhydroklorid
NO990214L (no) Anvendelse av nye glassblandinger i fremstilling av dentale glasspillarer og st°ttepilarer og fremgangsmÕte for Õ fremstille glasspilarer
DK0783391T3 (da) Håndloddeværktøj
ES2077173T3 (es) Composiciones y compuestos de eter vinilaromatico y procedimiento para su fabricacion.
BR0112745A (pt) Processo para a preparação de arilacetilaminotiazóis
ES2152563T3 (es) Procedimiento para preparar derivados de dihidroxipirimidina.
BR9714066A (pt) Processo para a preparação de derivados de tiazol.
DE69630115D1 (de) Steuerung der betondehnung infolge alkali-kieselsäure reaktion
NZ332840A (en) 1-[2-(pyridin-2-ylmethoxy)pyridin-5ylcarbamoyl]-indoline derivatives
LV12733A (lv) A novel crystalline form of 6-hydroxy-3- (4-¬2-(piperidin-1-yl) ethoxy¾ phenoxy)-2-(4-methoxyphenyl) benzo ¬b¾ thiophene hydrochloryde
NO20025520L (no) Apparat for å varme damp
BR0214578A (pt) Compostos azopolicìclicos fundidos com arila
RU2001131192A (ru) Композиция для изготовления теплоизоляционного материала
NO950501D0 (no) Fremgangsmåte til å oppnå 3-æ2[4-(6-fluoro-benzo[dÅisoxazol-3-yl)piperidin-1-ylÅ-etylå-2-metyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-aÅpyrimidin-4-on
FI955387A0 (fi) 4(p-fluorifenyyli)-3-((3,4-(metyleenioksi)fenoksi)metyyli)-piperidiinin N-p-halobentsoyylimetyylijohdannaiset
NZ333229A (de)
NO20015202L (no) <beta>-Hydroksyalkylamider, fremgangsmåte for deres fremstilling og deres anvendelse
NO964522L (no) Fremgangmåte ved fremstilling av 5,6-dihydroksy-2-amino-1,2,3,4-tetrahydronaftalenderivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application